| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Note on Population Analysis of Dissolution-Absorption Models Using the Inverse Gaussian Function
|
Jian Wang,
|
|
2008
|
48 |
6 |
p. 719-725
|
article
|
| 2 |
Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects
|
Schwartz, Jules I.
|
|
2008
|
48 |
6 |
p. 745-754
|
article
|
| 3 |
Cutaneous Pharmacodynamics of a Toll-Like Receptor 7 Agonist, 852A, in Humans
|
Astry, Calvin
|
|
2008
|
48 |
6 |
p. 755-762
|
article
|
| 4 |
Dose- and Time-Dependent Pharmacokinetics of Midostaurin in Patients With Diabetes Mellitus
|
Yanfeng Wang,
|
|
2008
|
48 |
6 |
p. 763-775
|
article
|
| 5 |
DrugInteractions/Review: New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process
|
Huang, Shiew-Mei
|
|
2008
|
48 |
6 |
p. 662-670
|
article
|
| 6 |
Limitations of Using a Single Postdose Midazolam Concentration to Predict CYP3A-Mediated Drug Interactions
|
Penzak, Scott R.
|
|
2008
|
48 |
6 |
p. 671-680
|
article
|
| 7 |
Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, in Healthy Male Volunteers
|
Addy, Carol
|
|
2008
|
48 |
6 |
p. 734-744
|
article
|
| 8 |
Population Exposure-Response Modeling of Metformin in Patients With Type 2 Diabetes Mellitus
|
Ying Hong,
|
|
2008
|
48 |
6 |
p. 696-707
|
article
|
| 9 |
Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment-Failure Gout
|
Corinne Seng Yue,
|
|
2008
|
48 |
6 |
p. 708-718
|
article
|
| 10 |
Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis
|
Zhenhua Xu,
|
|
2008
|
48 |
6 |
p. 681-695
|
article
|
| 11 |
Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval
|
Iwamoto, M.
|
|
2008
|
48 |
6 |
p. 726-733
|
article
|
Journal description